🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11395+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11395 recruiting trials

Phase 2RecruitingNCT06627179

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

🏥 Laboratoires Thea📍 27 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06563505

A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

👨‍⚕️ Dai Chihara, MD,PHD, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2024View details ↗
EARLY_Phase 1RecruitingNCT06718270

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

👨‍⚕️ Juan Du, Ph D, Shanghai Changzheng Hospital📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06736613

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

👨‍⚕️ Jennifer Lue, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06693830

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

👨‍⚕️ Hua-Jay J Cherng, MD, Columbia University📍 1 site📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT05421858

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

👨‍⚕️ Manuel Häckl, MD, Basilea Pharmaceutica International Ltd, Allschwil📍 130 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06573554

Contact Cast Versus Posterior Slab as Offloading Modality for Charcot Neuroarthropathy

👨‍⚕️ Ashu Rastogi, DM MD, PGIMER, India📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT05756985

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

👨‍⚕️ Manmeet S Ahluwalia, M.D., Miami Cancer Institute at Baptist Health, Inc.📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06608511

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

👨‍⚕️ Vincent Ma, MD, University of Wisconsin, Madison📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06630234

A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

👨‍⚕️ Clinical Team, Deciphera Pharmaceuticals, LLC📍 10 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06792786

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

🏥 The Central Hospital of Lishui City📍 2 sites📅 Started Dec 2024View details ↗
RecruitingNCT06733740

Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

👨‍⚕️ Yukun Luo, Chinese PLA General Hospital📍 1 site📅 Started Dec 2024View details ↗
Enrolling by InvitationNCT06805591

Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study

👨‍⚕️ Henrik W Schytz, MD, Ph.D. DMSc, Danish Headache Center📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06684119

Pediatric Positive End Expiratory Pressure (PEEP) Titration Using Electrical Impedence Tomography (EIT)

👨‍⚕️ Anoopindar Bhalla, MD, Children's Hospital Los Angeles📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06726577

TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis

🏥 Talengen Institute of Life Sciences, Shenzhen, P.R. China.📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06701357

CR-CHOP+X in Previously Untreated DEL

🏥 Ruijin Hospital📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06667453

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

🏥 PepGen Inc📍 8 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06358469

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

👨‍⚕️ Amy Jamieson, University of British Columbia, Vancouver, BC, Canada📍 10 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06566742

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

👨‍⚕️ Kelly Chien, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06894654

DERMATOMICS: Identifying Regulators of Skin Homeostasis

🏥 Relation Therapeutics📍 2 sites📅 Started Dec 2024View details ↗
← PreviousPage 190 of 570Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →